21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 148 0 0 0 0 0 02/28/2011 448 183
            148 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 48 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   59 0 0 0 0 0      
            107 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 10 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   6 0 0 0 0 0      
            16 0 0 0 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 13 13 12 2 1 0 09/17/2018 207 91
            13 13 12 2 1 0      
 
    2 Y 1 Control (Usual Care) 739 1 1 1 0 0 0 09/17/2018    
            1 1 1 0 0 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 80 0 0 0 0 0 05/14/2019 5 1
            80 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 29 25 13 2 0 0 09/24/2018 350 142
            29 25 13 2 0 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 7 7 7 3 1 0 09/24/2018    
        2 SST + Surgery/RT   10 10 8 4 1 0      
            17 17 15 7 2 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 5 3 1 1 1 1 05/04/2020 344 131
        2 MRI brain surveillance   1 1 0 0 0 0      
            6 4 1 1 1 1      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 Y 1 Active Symptom Monitoring + Patient Education 540 23 19 14 10 4 3 03/29/2023 231 106
        2 Patient Education   27 19 9 8 2 0      
            50 38 23 18 6 3      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 44 27 0 0 0 0 09/13/2021 210 116
            44 27 0 0 0 0      
 
  S0702-Zoledronic Acid ONJ Registry 1 N 1 Observation for ONJ 3500 57 0 0 0 0 0 01/30/2009    
            57 0 0 0 0 0      
 
  S0819-NSCLC, ADV, CHEMO/BEV +/-CET 1 N 1 Chemo+/-Bev w/o Cetuximab 1700 1 0 0 0 0 0 08/13/2009    
        2 Chemo+/-Bev w/ Cetuximab   1 0 0 0 0 0      
            2 0 0 0 0 0      
 
No EA1151-Prev, Tomosynthesis Mammographic Screening 1 E Total Registrations   105 105 105 95 34 14 01/30/2018 241 98
            105 105 105 95 34 14      
 

21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INCan

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 132 0 0 0 0 0 02/28/2011 448 183
            132 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 44 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   52 0 0 0 0 0      
            96 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 5 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   3 0 0 0 0 0      
            8 0 0 0 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 1 1 1 1 1 0 09/17/2018 207 91
            1 1 1 1 1 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 60 0 0 0 0 0 05/14/2019 5 1
            60 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 20 19 10 1 0 0 09/24/2018 350 142
            20 19 10 1 0 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 7 7 7 3 1 0 09/24/2018    
        2 SST + Surgery/RT   7 7 6 4 1 0      
            14 14 13 7 2 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 4 2 0 0 0 0 05/04/2020 344 131
        2 MRI brain surveillance   1 1 0 0 0 0      
            5 3 0 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 Y 1 Active Symptom Monitoring + Patient Education 540 14 14 12 9 4 3 03/29/2023 231 106
        2 Patient Education   8 8 5 5 2 0      
            22 22 17 14 6 3      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 13 13 0 0 0 0 09/13/2021 210 116
            13 13 0 0 0 0      
 
  S0702-Zoledronic Acid ONJ Registry 1 N 1 Observation for ONJ 3500 57 0 0 0 0 0 01/30/2009    
            57 0 0 0 0 0      
 
  S0819-NSCLC, ADV, CHEMO/BEV +/-CET 1 N 1 Chemo+/-Bev w/o Cetuximab 1700 1 0 0 0 0 0 08/13/2009    
        2 Chemo+/-Bev w/ Cetuximab   1 0 0 0 0 0      
            2 0 0 0 0 0      
 

21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INC, Bogota

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 16 0 0 0 0 0 02/28/2011 448 183
            16 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 4 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   7 0 0 0 0 0      
            11 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 2 Randomization Non-surgical Management 220 1 0 0 0 0 0 05/11/2015    
            1 0 0 0 0 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 10 0 0 0 0 0 05/14/2019 5 1
            10 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 4 3 1 0 0 0 09/24/2018 350 142
            4 3 1 0 0 0      
 
    2 Y 2 SST + Surgery/RT 1273 1 1 1 0 0 0 09/24/2018    
            1 1 1 0 0 0      
 

21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INEN

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 5 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   2 0 0 0 0 0      
            7 0 0 0 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 10 10 10 0 0 0 09/17/2018 207 91
            10 10 10 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 Y 1 Active Symptom Monitoring + Patient Education 540 8 4 1 1 0 0 03/29/2023 231 106
        2 Patient Education   16 8 4 3 0 0      
            24 12 5 4 0 0      
 

21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

GOCCHI

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 10 0 0 0 0 0 05/14/2019 5 1
            10 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 5 3 2 1 0 0 09/24/2018 350 142
            5 3 2 1 0 0      
 
    2 Y 2 SST + Surgery/RT 1273 2 2 1 0 0 0 09/24/2018    
            2 2 1 0 0 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 1 1 1 1 1 1 05/04/2020 344 131
            1 1 1 1 1 1      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 9 5 0 0 0 0 09/13/2021 210 116
            9 5 0 0 0 0      
 
No EA1151-Prev, Tomosynthesis Mammographic Screening 1 E Total Registrations   105 105 105 95 34 14 01/30/2018 241 98
            105 105 105 95 34 14      
 

21-DEC-2024 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

Univ Rep - Fac Med

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 2 2 1 1 0 0 09/17/2018 207 91
            2 2 1 1 0 0      
 
    2 Y 1 Control (Usual Care) 739 1 1 1 0 0 0 09/17/2018    
            1 1 1 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 Y 1 Active Symptom Monitoring + Patient Education 540 1 1 1 0 0 0 03/29/2023 231 106
        2 Patient Education   3 3 0 0 0 0      
            4 4 1 0 0 0      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 22 9 0 0 0 0 09/13/2021 210 116
            22 9 0 0 0 0